GTBP vs. NFLY

In the year-to-date period, GTBP achieves a -11.48% return, which is significantly lower than NFLY's 21.00% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for GT Biopharma, Inc. (GTBP) and YieldMax NFLX Option Income Strategy ETF (NFLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current GTBP Sharpe Ratio is -0.23, which is lower than the NFLY Sharpe Ratio of 2.27. The chart below compares the historical Sharpe Ratios of GTBP and NFLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

GTBP has not paid dividends to shareholders, while NFLY's dividend yield for the trailing twelve months is around 44.92%.

The maximum GTBP drawdown since its inception was -99.95%, which is greater than NFLY's maximum drawdown of -21.45%. Use the drawdown chart below to compare losses from any high point for GTBP and NFLY.

GT Biopharma, Inc. (GTBP) has a higher volatility of 25.81% compared to YieldMax NFLX Option Income Strategy ETF (NFLY) at 7.41%. This indicates that GTBP's price experiences larger fluctuations and is considered to be riskier than NFLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.